金陵药业股份有限公司2026年第一次临时股东会决议公告

Meeting Overview - The first extraordinary general meeting of shareholders for 2026 was held on February 5, 2026, at 14:30, combining both on-site and online voting methods [2][3] - The meeting was presided over by the chairman, Mr. Chen Sheng, and complied with relevant laws and regulations [3][10] Attendance - A total of 205 shareholders attended the meeting, representing 37,147,263 shares, which is 5.9730% of the total voting shares [4][5] - Among them, 2 shareholders attended in person, representing 14,800 shares (0.0024%), while 203 shareholders participated via online voting, representing 37,132,463 shares (5.9706%) [4][5] Voting Results - The proposal regarding the expected daily related transactions for 2026 was approved, with 34,922,902 shares in favor (94.0120%), 2,059,361 shares against (5.5438%), and 165,000 shares abstaining (0.4442%) [9] - The related shareholder, Nanjing New Industry Investment Group Co., Ltd., abstained from voting on this proposal, holding 259,390,380 shares [8] Legal Opinion - The legal opinion provided by Jiangsu Taihe Law Firm confirmed that the meeting's procedures and voting results were in compliance with applicable laws and regulations [10]